(Q34487119)

2 August 2017

1 reference

title

Lyme neuroborreliosis-epidemiology, diagnosis and management (English)

1 reference

2 August 2017

0 references

2

Volker Fingerle

1 reference

2 August 2017

Uwe Koedel

1

1 reference

2 August 2017

Hans-Walter Pfister

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

28 July 2015

1 reference

2 August 2017

Nature Reviews Neurology

1 reference

2 August 2017

11

1 reference

2 August 2017

8

1 reference

2 August 2017

446-456

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2015.121

2 August 2017

0 references

cites work

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic neurologic manifestations of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme disease incidence in Wisconsin: a comparison of state-reported rates and rates from a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

How big is the Lyme problem? Using novel methods to estimate the true number of Lyme disease cases in British Columbia residents from 1997 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme disease testing by large commercial laboratories in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Geographical and genospecies distribution of Borrelia burgdorferi sensu lato DNA detected in humans in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Borrelia bavariensis sp. nov. is widely distributed in Europe and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Prevalence, diversity, and load of Borrelia species in ticks that have fed on humans in regions of Sweden and Åland Islands, Finland with different Lyme borreliosis incidences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Strain-specific variation of the decorin-binding adhesin DbpA influences the tissue tropism of the lyme disease spirochete

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Suspected early Lyme neuroborreliosis in patients with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Toward a better understanding of European lyme neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neuroborreliosis--an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neurologic manifestations in Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Vasculitis and stroke due to Lyme neuroborreliosis - a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Peripheral neuropathy in acrodermatitis chronica atrophicans - effect of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic symptoms are common in patients with neuroborreliosis -- a questionnaire follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Long-term follow-up of patients with culture-confirmed Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

European neuroborreliosis: quality of life 30 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Risk factors for a non-favorable outcome after treated European neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Long-term Outcomes of Persons With Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Subjective symptoms after treatment of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic Lyme disease: the controversies and the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Persistent symptoms following treatment of early Lyme disease: false hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme disease: neurology, neurobiology, and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

A Critical Appraisal of “Chronic Lyme Disease”

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic fatigue syndrome following infections in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Persistence of Borrelia burgdorferi following antibiotic treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic Lyme Disease and Co-infections: Differential Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Update on persistent symptoms associated with Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Psychiatric comorbidity and other psychological factors in patients with "chronic Lyme disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The phenomenon of 'chronic Lyme'; an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The pain of "chronic Lyme disease": moving the discourse in a different direction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Placebo effects: from the neurobiological paradigm to translational implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Cognitive functioning in people with chronic fatigue syndrome: a comparison between subjective and objective measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Laboratory evaluation in the diagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Microbiological and serological diagnosis of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme disease: diagnostic issues and controversies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The Lymphocyte Transformation Test for Borrelia Detects Active Lyme Borreliosis and Verifies Effective Antibiotic Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Can ELISPOT Be Applied to A Clinical Setting as A Diagnostic Utility for Neuroborreliosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Decreased CD57 lymphocyte subset in patients with chronic Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Xenodiagnosis for posttreatment Lyme disease syndrome: resolving the conundrum or adding to it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Evaluation of two commercially available rapid diagnostic tests for Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Three Major Lyme Borrelia Genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) Identified by PCR in Cerebrospinal Fluid from Patients with Neuroborreliosis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronische lymphocytäre Meningitis, entzündliche Polyneuritis und „Rheumatismus”

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neurologic Abnormalities of Lyme Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

CDC estimates 300,000 US cases of Lyme disease annually

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Stages and syndromes of neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Catatonic syndrome in acute severe encephalitis due to Borrelia burgdorferi infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Acute transverse myelitis as presenting neurological feature of Lyme disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Incidence of Lyme borreliosis in the Würzburg region of Germany

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Borrelia encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Stroke due to lyme neuroborreliosis: changes in vessel wall contrast enhancement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Neuropathy associated with acrodermatitis chronica atrophicans. Clinical and morphological features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Psychiatric ethics and health services research. Concepts and research strategies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic polyneuropathy and Lyme disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Lyme neuroborreliosis. Peripheral nervous system manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Clinical and serologic follow-up in patients with neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

5-y Follow-up Study of Patients with Neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Symptoms of post-Lyme syndrome in long-term outcome of patients with neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Proof that chronic lyme disease exists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The lymphocyte transformation test for the diagnosis of Lyme borreliosis has currently not been shown to be clinically useful

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

A prospective study on the role of CXCL13 in Lyme neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

[CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Doxycycline versus ceftriaxone for the treatment of patients with chronic Lyme borreliosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

Chronic Lyme disease: a survey of Connecticut primary care physicians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.121

The genospecies B. burgdorferi s.l., isolated from ticks and from neurological patients with suspected Lyme borreliosis.

31 March 2020

1 reference

12 December 2020

Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis

1 reference

12 December 2020

Follow-up of antibiotically treated and untreated neuroborreliosis

1 reference

12 December 2020

LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity.

1 reference

12 December 2020

Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis

1 reference

12 December 2020

Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

1 reference

12 December 2020

Analysis of the intrathecal immune response in neuroborreliosis to a sonicate antigen and three recombinant antigens of Borrelia burgdorferi sensu stricto.

1 reference

12 December 2020

Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease.

1 reference

12 December 2020

A war over Lyme disease

1 reference

12 December 2020

Polyneuropathy in late Lyme borreliosis - a clinical, neurophysiological and morphological description

1 reference

12 December 2020

Outcomes of children treated for Lyme disease

1 reference

12 December 2020

Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases.

1 reference

12 December 2020

Molecular diagnosis of Lyme disease: review and meta-analysis

1 reference

12 December 2020

Surveillance for Lyme disease--United States, 1992-2006.

1 reference

12 December 2020

10.1038/NRNEUROL.2015.121

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference